Summary:
A double-blind, randomized study to investigate nonhormonal study medication for the treatment of vasomotor (Hot Flashes) in postmenopausal women. Study length is 30 weeks with 10 office visits.
Qualified Participants Must:
• Be Postmenopausal Women, age 40-65 experiencing moderate to severe Hot Flashes.
•
Must be in good general health.
•
BMI between 18-38.
Qualified Participants May Receive:
Nonhormonal study medication for the treatment of Postmenopausal Hot Flashes. Study related testing such as labs and physicals as well as female related testing.
Compensation for time and travel.